US$ 21.59
2024 asa guidance glp-1 receptor agonists perioperative A narrative review of glucagon-like peptide-1 prior to deep sedation or general anesthesia Glucagon-like Peptide-1 Receptor Agonists and
Description
Among the marketed large molecule injectable GLP-1 agonists, semaglutide, apart from weight-loss, is being studied for kidney disease and tirzepatide (a dual GLP-1 and GIP receptor agonist) is being evaluated for sleep apnea in Ph 3 clinical trials

What is Retatrutide
All Day

CNBC's Bertha Coombs joins 'Squawk on the Street' to report on Biden's administration plan to expand coverage of GLP-1 drugs for Americans with Medicare and Medicaid.
Weight Support*

Eli Lilly, makers of weight loss injection Zepbound, could soon be making its GLP-1 drug in pill form.
